Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enlivex Therapeutics Ltd.

1.22
+0.130011.93%
Post-market: 1.240.0200+1.64%19:54 EDT
Volume:236.81K
Turnover:287.44K
Market Cap:26.83M
PE:-1.26
High:1.29
Open:1.14
Low:1.12
Close:1.09
Loading ...
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Apr 30, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 10, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
May 03, 2022

Correspondence

CORRESP [Cover] - Correspondence
Apr 29, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Jun 04, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 30, 2021

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 10, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 09, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Aug 14, 2020

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
May 18, 2020

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 30, 2020

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 13, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 18, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 05, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 26, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]